## **Core Concept**
The question involves a two-month-old child presenting with epiphora (excessive tearing) and regurgitation, which are symptoms related to an ocular condition. The likely diagnosis is related to an abnormality in the nasolacrimal duct system.
## **Why the Correct Answer is Right**
The correct answer, **Dacryocystitis or more specifically, a nasolacrimal duct obstruction**, is the most probable diagnosis. In infants, the nasolacrimal duct may not be fully canalized at birth, leading to a condition known as nasolacrimal duct obstruction. This condition often presents with epiphora and regurgitation of mucoid material upon pressure over the lacrimal sac area (positive regurgitation test). This condition is common in infants and often resolves spontaneously by the age of 6-12 months.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include conditions such as conjunctivitis, blepharitis, or other ocular surface diseases that do not primarily present with regurgitation and are less likely to cause such specific symptoms in a neonate.
- **Option B:** Similarly, without the specific text, we can infer that any condition not directly related to the nasolacrimal duct system or its obstruction would be incorrect.
- **Option C:** Again, without specifics, any alternative diagnosis not directly linked to the symptoms of epiphora and regurgitation in the context of a nasolacrimal duct issue would be incorrect.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that nasolacrimal duct obstruction in infants often resolves spontaneously within the first year of life. Initial management may involve conservative measures such as nasolacrimal duct massage. If symptoms persist beyond 12 months, further intervention like probing of the duct may be considered.
## **Correct Answer: D. Nasolacrimal duct obstruction.**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.